Mycobacteria: Bugs and bugbears (Two steps forward and one step back)

@article{Parish1999MycobacteriaBA,
  title={Mycobacteria: Bugs and bugbears (Two steps forward and one step back)},
  author={Tanya Parish and Neil G. Stoker},
  journal={Molecular Biotechnology},
  year={1999},
  volume={13},
  pages={191-200}
}
The use of molecular techniques to study the mycobacteria has advanced greatly since the first genomic libraries of Mycobacterium tuberculosis and M. leprae were constructed in 1985. However, there are still pitfalls for the unwary. Most of the problems associated with the use of molecular techniques to study mycobacteria can be related to one of the following problems: slow growth rate causing problems with contamination; the formation of macroscopic clumps when grown in culture; resistance to… Expand
Targeting the histidine pathway in Mycobacterium tuberculosis.
TLDR
A comprehensive overview of Mycobacterium tuberculosis histidine pathway enzymes as attractive targets for the development of new antimycobacterial agents is provided, mainly summarizing the previously reported inhibition data for Mtb or orthologous proteins. Expand
Computational exploration of transmission and acquisition of drug-resistant tuberculosis
TLDR
This research explored the transmission and acquisition of drug-resistant tuberculosis, and used modeling and algorithms in support of treatment and control of tuberculosis. Expand
Reduction of Human DNA Contamination in Clinical Cerebrospinal Fluid Specimens Improves the Sensitivity of Metagenomic Next-Generation Sequencing
TLDR
The results demonstrate that the use of mNGS of centrifuged supernatants from clinical CSF samples in patients with TBM and CM is a simple and effective method to improve the sensitivity of pathogen detection. Expand
Biochemical, Biophysical, and Structural Characterisation of Glutamate Racemase from Mycobacterium tuberculosis and Mycobacterium smegmatis
Glutamate racemase (MurI) is a favored target for antimicrobial development, and is an essential enzyme in M. tuberculosis, a pathogenic bacterium for which new medications are urgently needed. ThisExpand
Detection of extensively drug resistant pulmonary tuberculosis
TLDR
Management of MDR-TB and XDR TB is a challenge which should be undertaken by experienced clinicians at centers equipped with reliable laboratory service for mycobacterial culture and in vitro sensitivity testing as it requires prolonged use of expensive second-line drugs with a significant potential for toxicity. Expand
Molecular Diagnosis, Detection and Treatment of Drug Resistant Mycobacterium tuberculosis
TLDR
Pulmonary tuberculosis mainly results from reactivation of a tuberculous f ocus after hematogenous dissemination or lymphogenous spread from a primary, usually pulmonary focus, and may mimick other pathologies. Expand
Design, Synthesis, Characterization and Biological Evaluation of Some New Heterocyclic Derivatives as Anti-Tubercular Agents
INTRODUCTION: Tuberculosis is an infectious disease usually caused by the bacteria Mycobacterium tuberculosis. Tuberculosis may infect any part of the body, but most commonly occur in the lungsExpand
Homology modeling, molecular dynamics and inhibitor binding study on MurD ligase of Mycobacterium tuberculosis
TLDR
Few pharmacophoric features essential for Mtb-MurD ligase inhibitory activity are identified and which can further been utilized for the discovery of putative antitubercular chemotherapy. Expand
Design, synthesis and in vivo/in vitro screening of novel chlorokojic acid derivatives
TLDR
A series of novel Mannich bases of chlorokojic acid exhibit significant antitubercular activity in a MIC range of 4 to 32 µg/mL, especially compound 18 against M. avium. Expand
To Find out the Essentiality of Rv0526 Gene in Virulence of Mycobacterium tuberculosis by using In silico Approaches
Tuberculosis has emerged as a major world health problem, with almost one-third of the world population today infected with Mycobacterium tuberculosis H37Rv (M. tuberculosis). This gram-positive Expand
...
1
2
3
...

References

SHOWING 1-10 OF 81 REFERENCES
The molecular genetics of Mycobacterium tuberculosis.
  • G. Hatfull
  • Biology, Medicine
  • Current topics in microbiology and immunology
  • 1996
TLDR
The relatively young field of mycobacterial genetics thus includes the use of a number of different myCobacterial systems each of which is, however, relevant to the understanding of M. tuberculosis. Expand
Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis
TLDR
Efficient plasmid transformation of M. smegmatis will facilitate the analysis of mycobacterial gene function, expression and replication and thus aid in the development of BCG as a multivalent recombinant vaccine vector and in the genetic analysis of the virulence determinants of pathogenicMycobacteria. Expand
Enhanced gene replacement in mycobacteria.
TLDR
Four genes in three species were successfully knocked-out using non-replicating DNA pretreated with alkali, UV or in an ss form, and the use of these methods to enhance HR will greatly facilitate experiments to inactivate other genes in these important species. Expand
The role of polymerase chain reaction in the diagnosis of mycobacterial infections
TLDR
Improved and novel techniques are proving useful in the diagnosis of tuberculosis and the likely development of commercial test systems should result in the widespread and routine use of PCR in time, however, it must be remembered that the technique detects both live and dead bacteria and the precise clinical relevance of PCR results will need to be determined. Expand
Efficient transposition in mycobacteria: construction of Mycobacterium smegmatis insertional mutant libraries
TLDR
The Tn611 transposon was inserted into pCG63, a temperature-sensitive plasmid isolated from an Escherichia coli-mycobacterial shuttle vector which contains the pAL5000 and pUC18 replicons, to generate a large number of insertional mutations in Mycobacterium smegmatis. Expand
The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis bacillus Calmette-Guérin.
TLDR
Homologous recombination will be an invaluable genetic tool for deciphering the mechanisms of tuberculosis pathogenesis, a disease that causes 3 x 10(6) deaths a year worldwide. Expand
Isolation by genetic labeling of a new mycobacterial plasmid, pJAZ38, from Mycobacterium fortuitum
TLDR
Experiments showed pJAZ38 to be stably inherited in the absence of selection pressure and compatible with the most commonly used mycobacterial replicon, pAL5000, making it a useful tool for myCobacterial genetics. Expand
Targeted replacement of the mycocerosic acid synthase gene in Mycobacterium bovis BCG produces a mutant that lacks mycosides.
TLDR
Thin-layer and radio-gas chromatographic analyses of the lipids derived from [1-14C]propionate showed that the mutant was incapable of synthesizing mycocerosic acids and mycosides, and homologous recombination with double crossover was achieved in a slow-growing mycobacterium with an intron-containing RecA. Expand
A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates.
  • J. Liu, H. Nikaido
  • Chemistry, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1999
TLDR
This work has isolated a mycolate-deficient mutant strain of Mycobacterium smegmatis mc2-155 by chemical mutagenesis followed by screening for increased sensitivity to novobiocin and found that this mutant was hypersensitive to other hydrophobic compounds such as crystal violet, rifampicin, and erythromycin. Expand
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
TLDR
The complete genome sequence of the best-characterized strain of Mycobacterium tuberculosis, H37Rv, has been determined and analysed in order to improve the understanding of the biology of this slow-growing pathogen and to help the conception of new prophylactic and therapeutic interventions. Expand
...
1
2
3
4
5
...